| For: | Chiang KC, Chen TC. Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol 2009; 15(27): 3349-3354 [PMID: 19610135 DOI: 10.3748/wjg.15.3349] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i27/3349.htm |
| Number | Citing Articles |
| 1 |
Ashley H Davis-Yadley, Mokenge P Malafa. Vitamins in Pancreatic Cancer: A Review of Underlying Mechanisms and Future Applications. Advances in Nutrition 2015; 6(6) doi: 10.3945/an.115.009456
|
| 2 |
Michael J. Story. Zinc, ω-3 polyunsaturated fatty acids and vitamin D: An essential combination for prevention and treatment of cancers. Biochimie 2021; 181 doi: 10.1016/j.biochi.2020.11.019
|
| 3 |
Shang-long LIU, Yu-pei ZHAO, Meng-hua DAI, Lei YOU, Zhang WEN, Jian-wei XU. Vitamin D status and the risk of pancreatic cancer: a meta-analysis. Chinese Medical Journal 2013; 126(17) doi: 10.3760/cma.j.issn.0366-6999.20122850
|
| 4 |
Lori A. Plum, Hector F. DeLuca. Vitamin D, disease and therapeutic opportunities. Nature Reviews Drug Discovery 2010; 9(12) doi: 10.1038/nrd3318
|
| 5 |
Tracey G. Simon, Andrew T. Chan. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4) doi: 10.1016/j.cld.2020.06.002
|
| 6 |
Aruna V. Krishnan, Donald L. Trump, Candace S. Johnson, David Feldman. The Role of Vitamin D in Cancer Prevention and Treatment. Rheumatic Disease Clinics of North America 2012; 38(1) doi: 10.1016/j.rdc.2012.03.014
|
| 7 |
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, M. Helena Vasconcelos, Cristina P. R. Xavier. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals 2021; 14(3) doi: 10.3390/ph14030280
|
| 8 |
Michael J. Story. Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer. Biochimie 2021; 187 doi: 10.1016/j.biochi.2021.05.013
|
| 9 |
Xi Zhang, Xuan-Zhang Huang, Wen-Jun Chen, Jian Wu, You Chen, Cong-Cong Wu, Zhen-Ning Wang. Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget 2017; 8(38) doi: 10.18632/oncotarget.18888
|
| 10 |
Wei Luo, Pamela A. Hershberger, Donald L. Trump, Candace S. Johnson. 24-Hydroxylase in cancer: Impact on vitamin D-based anticancer therapeutics. The Journal of Steroid Biochemistry and Molecular Biology 2013; 136 doi: 10.1016/j.jsbmb.2012.09.031
|
| 11 |
Bo Tang, Jimmy Y.C. Chow, Tobias Xiao Dong, Shi-Ming Yang, De-Sheng Lu, John M. Carethers, Hui Dong. Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca2+/β-catenin signaling pathway. Cancer Letters 2016; 377(1) doi: 10.1016/j.canlet.2016.04.027
|
| 12 |
Kun-Chun Chiang, Chun-Nan Yeh, Cheng-Cheng Huang, Ta-Sen Yeh, Jong-Hwei S. Pang, Jun-Te Hsu, Li-Wei Chen, Sheng-Fong Kuo, Atsushi Kittaka, Tai Chen, Horng-Heng Juang. 25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)2D3. International Journal of Molecular Sciences 2016; 17(8) doi: 10.3390/ijms17081326
|
| 13 |
Alexandra Irimie, Cornelia Braicu, Sergiu Pasca, Lorand Magdo, Diana Gulei, Roxana Cojocneanu, Cristina Ciocan, Andrei Olariu, Ovidiu Coza, Ioana Berindan-Neagoe. Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention. Medicina 2019; 55(6) doi: 10.3390/medicina55060283
|
| 14 |
Min Yang, Yuping Xu, Donghui Pan, Lizhen Wang, Shineng Luo, Guoqiang Shao, Lu Liu, Peilin Hunag. Bioevaluation of a novel [32P]‐CP‐PLLA microparticle for pancreatic cancer treatment. Drug Development Research 2010; 71(6) doi: 10.1002/ddr.20379
|
| 15 |
Jing Li, Haiyan Zhang, Hongda Zhu, Zhu Dai. 25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis. Nutrition Research 2023; 117 doi: 10.1016/j.nutres.2023.07.001
|
| 16 |
Jiawei Rao, Xukun Wu, Xiaozhuan Zhou, Ronghai Deng, Yi Ma. Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.85075
|
| 17 |
Priti Paul, Rahul Nair, Srushti Mahajan, Ujala Gupta, Mayur Aalhate, Indrani Maji, Rahul Kumar, Anshita Gupta Soni, Pankaj Kumar Singh. Nutraceuticals: A New Millennium Approach for Preventive Medicine. Food Bioactive Ingredients 2024; doi: 10.1007/978-3-031-76481-3_4
|
| 18 |
. 2018; doi: 10.70675/acc680a1zecfdz4c85z8f27z1fd05d90a500
|
| 19 |
Yang Zhang, Tao Zhang, Wenbo Yang, Hongze Chen, Xinglong Geng, Guanqun Li, Hua Chen, Yongwei Wang, Le Li, Bei Sun. Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.630972
|
| 20 |
Ping Wang, Jiming Xu, Weijing You, Yongfeng Hou, Shuiliang Wang, Yujie Ma, Jianming Tan, Zengli Zhang, Wentao Hu, Bingyan Li. Knockdown of CYP24A1 Aggravates 1α,25(OH)2D3-Inhibited Migration and Invasion of Mouse Ovarian Epithelial Cells by Suppressing EMT. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01258
|
| 21 |
Lina Yang, Jianfei Ma, Xiuli Zhang, Yi Fan, Lining Wang. Protective role of the vitamin D receptor. Cellular Immunology 2012; 279(2) doi: 10.1016/j.cellimm.2012.10.002
|
| 22 |
Mark M. Kushnir, Julie A. Ray, Alan L. Rockwood, William L. Roberts, Sonia L. La’ulu, JoDell E. Whittington, A. Wayne Meikle. Rapid Analysis of 25-Hydroxyvitamin D2and D3by Liquid Chromatography–Tandem Mass Spectrometry and Association of Vitamin D and Parathyroid Hormone Concentrations in Healthy Adults. American Journal of Clinical Pathology 2010; 134(1) doi: 10.1309/AJCPPIA7DFBT4GKS
|
| 23 |
Brian M. Wolpin, Kimmie Ng, Ying Bao, Peter Kraft, Meir J. Stampfer, Dominique S. Michaud, Jing Ma, Julie E. Buring, Howard D. Sesso, I-Min Lee, Nader Rifai, Barbara B. Cochrane, Jean Wactawski-Wende, Rowan T. Chlebowski, Walter C. Willett, JoAnn E. Manson, Edward L. Giovannucci, Charles S. Fuchs. Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention 2012; 21(1) doi: 10.1158/1055-9965.EPI-11-0836
|
| 24 |
Enikö Kallay, Martin Schepelmann, Laura Buburuzan. Feldman and Pike's Vitamin D. 2024; doi: 10.1016/B978-0-323-91338-6.00037-9
|
| 25 |
Kun-Chun Chiang, Chun-Nan Yeh, Tai C. Chen. Vitamin D and Pancreatic Cancer—An Update. Cancers 2011; 3(1) doi: 10.3390/cancers3010213
|
| 26 |
Aruna V. Krishnan, Donald L. Trump, Candace S. Johnson, David Feldman. The Role of Vitamin D in Cancer Prevention and Treatment. Endocrinology and Metabolism Clinics of North America 2010; 39(2) doi: 10.1016/j.ecl.2010.02.011
|
| 27 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2010; 17(4) doi: 10.1097/MED.0b013e32833c4b2b
|
| 28 |
Mohammed O Ibrahim, Haya Abuhijleh, Reema Tayyem. What Dietary Patterns and Nutrients are Associated with Pancreatic Cancer? Literature Review. Cancer Management and Research 2023; doi: 10.2147/CMAR.S390228
|
| 29 |
Yajing Shen, Junfen Xia, Chuncheng Yi, Tiandong Li, Peng Wang, Liping Dai, Jianxiang Shi, Keyan Wang, Changqing Sun, Hua Ye. The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies. European Journal of Nutrition 2024; 63(3) doi: 10.1007/s00394-023-03302-w
|
| 30 |
Navid Tabriz, Verena Nicole Uslar, Dennis Obonyo, Dirk Weyhe. Micronutritional status after pylorus preserving duodenopancreatectomy: analysis of data from a randomized controlled trial. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-97438-6
|
| 31 |
Ana C. Liaudat, Luciana P. Bohl, Nori G. Tolosa de Talamoni, Belkys Maletto, María C. Pistoresi-Palencia, Gabriela Picotto. Oxidative stress, cell cycle arrest and differentiation contribute toward the antiproliferative action of BSO and calcitriol on Caco-2 cells. Anti-Cancer Drugs 2014; 25(7) doi: 10.1097/CAD.0000000000000109
|
| 32 |
|
| 33 |
|
| 34 |
Kun-Chun Chiang, Chun-Nan Yeh, Shin-Cheh Chen, Shih-Che Shen, Jun-Te Hsu, Ta-sen Yeh, Jong-Hwei S. Pang, Li-Jen Su, Masashi Takano, Atsushi Kittaka, Horng-Heng Juang, Tai C. Chen. MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D3in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2012; 2012 doi: 10.1155/2012/310872
|
| 35 |
Candace Miyaki, Launa M Lynch. An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer. Cureus 2022; doi: 10.7759/cureus.25496
|
| 36 |
Guoqing Wang, Lei Lei, Xixia Zhao, Jun Zhang, Min Zhou, Kejun Nan. Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2015; 22(5) doi: 10.3727/096504015X14424348425991
|
| 37 |
. 2020; doi: 10.70675/252d1be2z22e8z4378zb146zfd4ec7fa46a7
|
| 38 |
Ebtesam Abdullah Al-Suhaimi, Khulood Mohammed Al-Khater, Meneerah Abdurhman Aljafary, Vijaya Ravinayagam, Adeeb Shehzad, Hanan A. Al-Dossary, Reem A. Assuhaimi, Mohamad Tarhini, Abdelhamid Elaissari. Cancer-Leading Proteases. 2020; doi: 10.1016/B978-0-12-818168-3.00015-2
|
| 39 |
Kun-Chun Chiang, Chun-Nan Yeh, Huang-Yang Chen, Jim-ming Lee, Horng-Heng Juang, Miin-Fu Chen, Masashi Takano, Atsushi Kittaka, Tai C. Chen. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells. Steroids 2011; 76(13) doi: 10.1016/j.steroids.2011.08.006
|
| 40 |
Panida Lungchukiet, Yuefeng Sun, Ravi Kasiappan, Waise Quarni, Santo V. Nicosia, Xiaohong Zhang, Wenlong Bai. Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor. The Journal of Steroid Biochemistry and Molecular Biology 2015; 148 doi: 10.1016/j.jsbmb.2014.11.005
|
| 41 |
Vicente Andrés. Vitamin D puts the brakes on angiotensin II-induced oxidative stress and vascular smooth muscle cell senescence. Atherosclerosis 2014; 236(2) doi: 10.1016/j.atherosclerosis.2014.07.031
|
| 42 |
Silvia D. Stan, Shivendra V. Singh, Randall E. Brand. Chemoprevention strategies for pancreatic cancer. Nature Reviews Gastroenterology & Hepatology 2010; 7(6) doi: 10.1038/nrgastro.2010.61
|
| 43 |
Kun‐Chun Chiang, Chun‐Nan Yeh, Miin‐Fu Chen, Tai C Chen. Hepatocellular carcinoma and vitamin D: A review. Journal of Gastroenterology and Hepatology 2011; 26(11) doi: 10.1111/j.1440-1746.2011.06892.x
|
| 44 |
Pubudu Bulathsinghala, Kostas N. Syrigos, Muhammad W. Saif. Role of Vitamin D in the Prevention of Pancreatic Cancer. Journal of Nutrition and Metabolism 2010; 2010 doi: 10.1155/2010/721365
|
| 45 |
Indranil Chattopadhyay. Pharmacotherapeutic Botanicals for Cancer Chemoprevention. 2020; doi: 10.1007/978-981-15-5999-0_7
|
| 46 |
Kun-Chun Chiang, Chun-Nan Yeh, Jun-te Hsu, Ta-sen Yeh, Yi-yan Jan, Chun-tw Wu, Huang-yang Chen, Shyh-chuan Jwo, Masashi Takano, Atsushi Kittaka, Horng-Heng Juang, Tai Chen. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle 2013; 12(8) doi: 10.4161/cc.24445
|
| 47 |
Kun-Chun Chiang, Chun-Nan Yeh, Kun-Ju Lin, Li-Jen Su, Tzu-Chen Yen, Jong-Hwei S. Pang, Atsushi Kittaka, Chi-Chin Sun, Miin-Fu Chen, Yi-Yin Jan, Tai C. Chen, Horng-Heng Juang, Ta-Sen Yeh. Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Oncotarget 2014; 5(11) doi: 10.18632/oncotarget.2000
|
| 48 |
L K Johnson, D Hofsø, E T Aasheim, T Tanbo, K B Holven, L F Andersen, J Røislien, J Hjelmesæth. Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study. European Journal of Clinical Nutrition 2012; 66(1) doi: 10.1038/ejcn.2011.140
|
| 49 |
Ki Jin Kwon, Su Jin Jeong, Young-Gyu Eun, In Hwan Oh, Young Chan Lee. Risk of cancer in patients with recurrent aphthous stomatitis in Korea. Medicine 2021; 100(16) doi: 10.1097/MD.0000000000025628
|